Lucid M1 Transcranial Doppler Ultrasound System receives CE Mark for monitoring of patients with brain disorders.-Neural Analytics Inc.

Neural Analytics Inc., a medical device company developing technology to measure, diagnose and track brain health, announced that it received CE Mark for its next generation ultrasound device, the Lucid M1 Transcranial Doppler Ultrasound System (Lucid System).

The Lucid System, which received 510(k) clearance from the FDA in October 2016, is a portable all-in-one ultrasound system designed for rapid triaging and monitoring of patients with brain disorders. Neural Analytics expects to begin commercially selling the Lucid System in Europe immediately.

Comment:The Lucid System uses a type of ultrasound called Trans Cranial Doppler to assess the brain�s blood vessels from outside the body. This analysis is non-invasive, can be performed in the physician�s office, and can help the physician diagnose brain disorders, potentially without the need for additional, more invasive tests. Many significant brain disorders, such as severe traumatic brain injury (TBI), are caused by blood flow disruption. The Lucid System is a battery operated medical grade tablet device designed to be moved easily throughout a medical facility in a range of settings that require the rapid assessment of blood flow in the brain to expedite treatment.